Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/15/25 18:31 | 10/10/25 | CORT | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | D | 15 | S.d | -1,922 | 62.09 | 0 | -31 | -100 | 0 | D | |||||||||||||||
10/9/25 17:51 | 10/7/25 | CORT | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | 17 | S.dm | -14,050 | 63.86 | 0 | -220 | 6 | D | |||||||||||||||
10/3/25 17:24 | 10/1/25 | CORT | Health | Drug | Pharmaceutical Preparations | Belanoff Joseph K | CA | DO | CEO | 9 | S.dm | -18,904 | 78.45 | 0 | -241 | 3,019 | I | |||||||||||||||
10/3/25 17:17 | 10/1/25 | CORT | Health | Drug | Pharmaceutical Preparations | Lyon Joseph Douglas | CA | O | See Rema | 15 | S.dm | -23,989 | 91.77 | 0 | -261 | 10 | D | |||||||||||||||
10/3/25 17:15 | 10/1/25 | CORT | Health | Drug | Pharmaceutical Preparations | Maduck Sean | CA | O | See Rema | 12 | S.dm | -23,957 | 79.86 | 0 | -300 | 118 | D | |||||||||||||||
8/26/25 18:56 | 8/22/25 | CORT | Health | Drug | Pharmaceutical Preparations | Robb Gary Charles | CA | O | Chief Bu | 8 | S.d | -2,243 | 48.25 | 0 | -47 | 52 | D | |||||||||||||||
5/20/25 19:13 | 5/16/25 | CORT | Health | Drug | Pharmaceutical Preparations | Mahoney David L | CA | D | 1 | S.d | -2,030 | 74.23 | 0 | -27 | 1,259 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |